On November, 16th, we will discuss the highlights of the next-in-class drugs development

On November, 16th, at 11:00 am, we will hold a webinar on the “Highlights of the next-in-class drugs development”.

The development of pharmacologically similar agents and improved analogues of innovative drugs (next-in-class) is one of the target directions in evolution of Russian pharmaceutical industry under the “Pharma 2020” program.

Register to the webinar

What will we discuss at the webinar?

  • the advantages and risks of next-in-class drug development;

  • specifics of these drugs clinical trials program planning;

  • the applicability of adaptive designs using in clinical trials of the next-in-class drug on the example of different pharmacological classes.

For whom?

For drug developers, pharmaceutical and biotech companies, participants in the clinical trial market, doctors.


Natalia Vostokova, IPHARMA Chief Operating Officer

Julia Tahtenberg, IPHARMA Medical Director

How to participate?

To participate in the webinar you should register.

On November, 16th, you will receive an email invitation with a link to the broadcast.

Participation is free of charge.

Can I ask the questions?

You can ask preliminary questions which you would like to discuss in the registration application.

It is also possible to ask questions in Chat form during the broadcast on the YouTube channel, you will need to log in with your Google Account or create a new account.

What if I miss the webinar?

All webinars are recorded and you can watch it on YouTube IPHARMA channel.

#webinar #nextinclass

Недавние посты